Glutamine supplementation in catabolic illness.
Glutamine supplementation in catabolic illness.
复制标题
分解代谢疾病中的谷氨酰胺补充剂。
DOI:
10.1093/ajcn/64.4.645
复制
发表时间:
1996
期刊:
影响因子:
--
通讯作者:
Ziegler,TR
中科院分区:
文献类型:
--
作者:
Ziegler,TR
The administration of tissue-specific nutrients is increasingly being investigated as an approach to enhance the efficacy of specialized enteral and parenteral nutrition support. Numerous animal studies and clinical investigations have evaluated the metabolic and clinical effects of diets supplemented with glutamine (1). Glutamine is the most abundant amino acid in plasma and the body and it exhibits dynamic interorgan metabolism between skeletal muscle pools, the splanchnic bed, kidney, and other tissues. Glutamine is a major participant in gluconeogenesis, RNA and DNA synthesis, and acid-base balance. It is used as a major fuel and substrate in rapidly repli-cating tissues such as the intestinal mucosa and cells of the immune system (1-3). Data from both human and animal studies support the concept that glutamine becomes condition-ally essential during catabolic illness (1-3). Enteral and/or parenteral glutamine supplementation in animal models of catabolic stress clearly improves important end points, such as nitrogen retention, intestinal mucosal growth and repair, gut barrier function, immune cell number and function, infection resistance, and animal survival (1, 2). Thus, glutamine appears to be one of several amino acids, including histidine, arginine, taurine, and cysteine, which are semiessential or conditionally essential in human nutrition(4).In this issue of the Journal, Jensen et al (5) describe the metabolic results of a double-blind, randomized, prospective controlled trial of glutamine-enriched enteral tube feedings compared with standard low-glutamine enteral tube feedings in critically ill adults in an intensive care unit (ICU). Clinically matched patients were studied during a l0-d period after ICU admission for multiple trauma or head injury. Control and experimental tube feedings were started< 48 h after ICU admission. The diets were isoenergetic and isonitrogenous and differed only in the amount of certain nonessential acids used to replace glutamine nitrogen. The major difference between the diets was a nearly six-fold increase in glutamine content in the glutamine-enriched experimental formula, which provided 28.9% of dietary protein intake as L-glutamine(0.3 g kg‘. d ‘) compared with 5.0% of the dietary protein in the control low-glutamine diet (5). Use of the glutamine-enriched diet did not alter indexes of systemic inflammation or catabolic stress, which declined similarly in each group over time. Nitrogen balance and serum albumin and prealbumin concentrations also remained similar in the control and experimental groups (5). Both study groups remained in negative nitrogen balance throughout the study period. which shows the difficulty in achieving anabolism in